...
首页> 外文期刊>Protein Science: A Publication of the Protein Society >Structures of S. aureus thymidylate kinase reveal an atypical active site configuration and an intermediate conformational state upon substrate binding.
【24h】

Structures of S. aureus thymidylate kinase reveal an atypical active site configuration and an intermediate conformational state upon substrate binding.

机译:金黄色葡萄球菌胸苷酸激酶的结构在底物结合后显示出非典型的活性位点构型和中间构象状态。

获取原文
获取原文并翻译 | 示例
           

摘要

Methicillin-resistant Staphylococcus aureus (MRSA) poses a major threat to human health, particularly through hospital acquired infection. The spread of MRSA means that novel targets are required to develop potential inhibitors to combat infections caused by such drug-resistant bacteria. Thymidylate kinase (TMK) is attractive as an antibacterial target as it is essential for providing components for DNA synthesis. Here, we report crystal structures of unliganded and thymidylate-bound forms of S. aureus thymidylate kinase (SaTMK). His-tagged and untagged SaTMK crystallize with differing lattice packing and show variations in conformational states for unliganded and thymidylate (TMP) bound forms. In addition to open and closed forms of SaTMK, an intermediate conformation in TMP binding is observed, in which the site is partially closed. Analysis of these structures indicates a sequence of events upon TMP binding, with helix alpha3 shifting position initially, followed by movement of alpha2 to close the substrate site. In addition, we observe significant conformational differences in the TMP-binding site in SaTMK as compared to available TMK structures from other bacterial species, Escherichia coli and Mycobacterium tuberculosis as well as human TMK. In SaTMK, Arg 48 is situated at the base of the TMP-binding site, close to the thymine ring, whereas a cis-proline occupies the equivalent position in other TMKs. The observed TMK structural differences mean that design of compounds highly specific for the S. aureus enzyme looks possible; such inhibitors could minimize the transfer of drug resistance between different bacterial species.
机译:耐甲氧西林金黄色葡萄球菌(MRSA)对人类健康构成重大威胁,尤其是通过医院获得性感染。 MRSA的传播意味着需要新的靶标来开发潜在的抑制剂来对抗这种耐药细菌引起的感染。胸苷酸激酶(TMK)作为抗菌靶标具有吸引力,因为它对于提供DNA合成成分至关重要。在这里,我们报告金黄色葡萄球菌胸苷酸激酶(SaTMK)的未配体和胸苷酸结合形式的晶体结构。带有His标签和未标签的SaTMK会以不同的晶格堆积方式结晶,并显示未配体和胸苷酸(TMP)结合形式的构象态变化。除了开放形式和封闭形式的SaTMK,还观察到TMP结合的中间构象,其中该位点是部分封闭的。对这些结构的分析表明,TMP结合后发生了一系列事件,最初是螺旋α3移位,随后α2移动以封闭底物位点。此外,与其他细菌,大肠杆菌和结核分枝杆菌以及人TMK可获得的TMK结构相比,我们在SaTMK中的TMP结合位点观察到显着的构象差异。在SaTMK中,Arg 48位于TMP结合位点的底部,靠近胸腺嘧啶环,而顺脯氨酸在其他TMK中的位置相同。观察到的TMK结构差异意味着设计对金黄色葡萄球菌酶高度特异的化合物似乎是可行的。这种抑制剂可以使不同细菌之间的耐药性转移最小化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号